VIRT-PHOS 250 NEUTRAL- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, mo

Nchi: Marekani

Lugha: Kiingereza

Chanzo: NLM (National Library of Medicine)

Viambatanisho vya kazi:

Sodium Phosphate, Dibasic, Anhydrous (UNII: 22ADO53M6F) (Phosphate Ion - UNII:NK08V8K8HR, Sodium Cation - UNII:LYR4M0NH37), Potassium Phosphate, Monobasic (UNII: 4J9FJ0HL51) (Phosphate Ion - UNII:NK08V8K8HR, Potassium Cation - UNII:295O53K152), Sodium Phosphate, Monobasic, Monohydrate (UNII: 593YOG76RN) (Phosphate Ion - UNII:NK08V8K8HR, Sodium Cation - UNII:LYR4M0NH37)

Inapatikana kutoka:

Virtus Pharmaceuticals

INN (Jina la Kimataifa):

Sodium Phosphate, Dibasic, Anhydrous

Tungo:

Sodium Phosphate, Dibasic, Anhydrous 852 mg

Njia ya uendeshaji:

ORAL

Matibabu dalili:

As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age. Virt-Phos 250 Neutral increases urinary phosphate and pyrophosphate. This product is contraindicated in patients with infected phosphate stones in the urinary tract, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Bidhaa muhtasari:

Virt-Phos 250 Neutral is supplied as white tablet, imprinted "V268" dispensed in bottles of 100 tablets. 69543-268 -10 This product may - under certain circumstances, be dispensed through a certified mail-order program so long as there is record of prescription AND confirmation that the patient is under licensed medical supervision.

Idhini hali ya:

Dietary Supplement

Tabia za bidhaa

VIRT-PHOS 250 NEUTRAL- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM
PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC,
MONOHYDRATE TABLET
VIRTUS PHARMACEUTICALS
----------
VIRT-PHOS 250 NEUTRAL TABLETS
69543-268-10
RX
Phosphorous Dietary Supplement - supplying 250 mg phosphorous per
tablet
DESCRIPTION
Virt-Phos 250 Neutral is a prescription phosphorous dietary supplement
- supplying 250
mg phosphorous per tablet for use in the dietary management of
hypophosphatemia
and should be administered under the supervision of a licensed medical
practitioner.
SUPPLEMENT FACTS
SERVING SIZE: ONE TABLET
AMOUNT PER
SERVING
% DAILY VALUE
*
†
DIBASIC SODIUM PHOSPHATE
ANHYDROUS
852 mg
MONOBASIC POTASSIUM
PHOSPHATE
155 mg
MONOBASIC SODIUM
PHOSPHATE MONOHYDRATE
130 mg
Other Ingredients: Microcrystalline Cellulose, Croscarmellose Sodium,
Stearic Acid,
Magnesium Stearate, Silicon Dioxide.
ALLERGY STATEMENT
This product has been manufactured in a facility that also
manufactures products
containing tree nuts, peanuts, fish, egg, wheat, milk, soy and
shellfish. Individuals with
allergies to these substances should use discretion.
INDICATIONS AND USAGE
As a phosphorus supplement, each tablet supplies 25% of the U.S.
Recommended Daily
Allowance (U.S. RDA) of phosphorus for adults and children over 4
years of age.
Virt-Phos 250 Neutral increases urinary phosphate and pyrophosphate.
Each tablet yields approximately 250 mg (25% DV for adults) of
phosphorus, 298 mg sodium (13.0 mEq), and 45 mg of potassium (1.1
mEq).
Daily Value not established
*
†
*
†
*
†
CONTRAINDICATIONS
This product is contraindicated in patients with infected phosphate
stones in the urinary
tract, in patients with severely impaired renal function (less than
30% of normal) and in
the presence of hyperphosphatemia.
PRECAUTIONS
GENERAL
This product contains potassium and sodium and should be used with
caution if clinical
management of these elements is desired. Some individuals may
experience a mild
laxative effect during the first few days of phosphate therap